Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar Imhilion (21.67) Submitted: 1/11/2012 2:03:22 PM : Outperform Start Price: $0.52 BPAX Score: -3.65

Should rally as we approach Feb 14, High Risk High Reward FDA approval play

Report this Post Reply

Featured Broker Partners


Advertisement